Erratum to: Chemotherapy-Related Cognitive Dysfunction
نویسندگان
چکیده
منابع مشابه
An overview of chemotherapy-related cognitive dysfunction, or 'chemobrain'.
Chemotherapy can improve prospects for long-term survival after a cancer diagnosis, but it may also be associated with long-term toxicity, including the possibility of cognitive dysfunction. While a variety of factors may contribute to cognitive impairment in cancer survivors, there is increasing evidence that chemotherapy contributes to both subjective and objective changes in cognition. These...
متن کاملAn update on cancer- and chemotherapy-related cognitive dysfunction: current status.
The purpose of this review is to summarize the current literature on the effects of cancer treatment-related cognitive difficulties, with a focus on the effects of chemotherapy. Numerous patients have cognitive difficulties during and after cancer treatments and, for some, these effects last years after treatment. We do not yet fully understand which factors increase susceptibility to cognitive...
متن کاملChemotherapy-related changes in cognitive functioning
1359-6349/$ see front matter Copyright 2013 ECCO the European CanCer Organisation. All rights reserved. http://dx.doi.org/10.1016/j.ejcsup.2013.07.007 * Corresponding author. Address: Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Ple 121, 1066 CX, Amsterdam, The Netherlands. Tel.: +31 20 512 2328/2480. E-mail address: [email protected] (S.B. Schagen). Sann...
متن کاملEpidemiology of Cancer-related Cognitive Dysfunction
Cancer-related cognitive dysfunction (CRCD)—especially impairments in attention and memory—constitutes a significant problem for cancer patients and survivors. Incidence rates of CRCD range from 17 to 75%. Cognitive impairment experienced by cancer patients can be severe and long-lasting. Strategies to ameliorate this condition have been hindered by difficulties in understanding the precise eti...
متن کاملStem cell transplantation reverses chemotherapy-induced cognitive dysfunction.
The frequent use of chemotherapy to combat a range of malignancies can elicit severe cognitive dysfunction often referred to as "chemobrain," a condition that can persist long after the cessation of treatment in as many as 75% of survivors. Although cognitive health is a critical determinant of therapeutic outcome, chemobrain remains an unmet medical need that adversely affects quality of life ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Neurology and Neuroscience Reports
سال: 2012
ISSN: 1528-4042,1534-6293
DOI: 10.1007/s11910-012-0271-x